Results 21 to 30 of about 150,928 (204)

Wyniki leczenia operacyjnego chorych na chrzęstniakomięsaki miednicy z oszczędzeniem kończyny

open access: yesNowotwory, 2021
Analizie poddano 53 kolejnych chorych na chondrosarcoma (ChSa) kości miednicy i kości krzyżowej leczonych operacyjnie w Klinice Nowotworów Tkanek Miękkich, Kości i Czerniaków Narodowego Instytutu Onkologii im.
Andrzej Pieńkowski   +9 more
doaj   +1 more source

Diagnostic Value of Serum LncRNAs for Bone Metastasis in Lung Cancer

open access: yesZhongliu Fangzhi Yanjiu, 2022
Objective To investigate the expression of lncRNA HOTAIR, HOTAIR, CRNDE and AFAP1-AS1 in lung cancer patients with bone metastasis (LCWBM), and to elucidate the diagnostic value of lncRNAs for LCWBM. Methods Serum was collected from 38 LCWBM patients and
ZHANG Peng   +5 more
doaj   +1 more source

Safety and efficacy of stereotactic body radiation therapy in the treatment of pulmonary metastases from high grade sarcoma. [PDF]

open access: yes, 2013
Introduction. Patients with high-grade sarcoma (HGS) frequently develop metastatic disease thus limiting their long-term survival. Lung metastases (LM) have historically been treated with surgical resection (metastasectomy).
Agazaryan, Nzhde   +9 more
core   +2 more sources

Insurance impacts survival for children, adolescents, and young adults with bone and soft tissue sarcomas. [PDF]

open access: yes, 2020
BackgroundWhile racial/ethnic survival disparities have been described in pediatric oncology, the impact of income has not been extensively explored. We analyzed how public insurance influences 5-year overall survival (OS) in young patients with sarcomas.
Goldsby, Robert E   +5 more
core   +1 more source

Non‐rhabdomyosarcoma soft‐tissue sarcoma [PDF]

open access: yesPediatric Blood & Cancer, 2021
AbstractNon‐rhabdomyosarcoma soft‐tissue sarcomas (NRSTS) comprise 4% of childhood cancers and consist of numerous histologic subtypes. Prognostic factors associated with poor outcome include high histologic grade, large tumor size, presence of metastases, and unresectability.
Sarah A. Milgrom   +5 more
openaire   +3 more sources

Zalecenia Polskiej Grupy Mięsakowej odnośnie postępowania diagnostyczno-terapeutycznego oraz kontroli u chorych na neurofibromatozę typu 1 (NF1) oraz malignant peripheral nerve sheath tumor związany z NF1

open access: yesNowotwory, 2022
Neurofibromatoza typu 1 (zespół NF1 in. choroba Recklinghausena, nerwiakowłókniakowatość typu 1), jest dziedziczona autosomalnie dominująco, a odpowiadają za nią mutacje genu NF1 kodującego białko neurofibrominy.
Piotr Rutkowski   +21 more
doaj   +1 more source

Analysis of margin classification systems for assessing the risk of local recurrence after soft tissue sarcoma resection [PDF]

open access: yes, 2018
Purpose: To compare the ability of margin classification systems to determine local recurrence (LR) risk after soft tissue sarcoma (STS) resection. Methods: Two thousand two hundred seventeen patients with nonmetastatic extremity and truncal STS ...
Catton, Charles N.   +9 more
core   +1 more source

Soft tissue sarcoma

open access: yesBMJ, 2016
#### What you need to know A 45 year old woman presented to her general practitioner several times over nine months with a gradually enlarging, hard lump in her anterior thigh. An ultrasound scan showed a solid intramuscular mass in the anterior compartment of her thigh, prompting a two week wait referral to the regional sarcoma diagnostic clinic ...
Eastley, Nicholas Charles   +2 more
openaire   +3 more sources

Epithelioid sarcoma

open access: yesNowotwory, 2023
Epithelioid sarcoma (ES) is a very rare sarcoma characterized by loss of INI1. Enzinger first described ES in 1970, butthe histopathologic differential diagnosis of ES remains challenging.
Anna M. Czarnecka
doaj   +1 more source

Characterizing the immune microenvironment of malignant peripheral nerve sheath tumor by PD-L1 expression and presence of CD8+ tumor infiltrating lymphocytes. [PDF]

open access: yes, 2016
BackgroundMalignant peripheral nerve sheath tumor (MPNST) is an aggressive sarcoma with few treatment options. Tumor immune state has not been characterized in MPNST, and is important in determining response to immune checkpoint blockade.
Bernthal, Nicholas   +11 more
core   +2 more sources

Home - About - Disclaimer - Privacy